Jiro Terada
Overview
Explore the profile of Jiro Terada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
109
Citations
684
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kinouchi T, Terada J, Sakao S, Koshikawa K, Sasaki T, Sugiyama A, et al.
Respirology
. 2022 Oct;
28(3):273-280.
PMID: 36184258
Background And Objective: The possibility of combination therapy with atomoxetine (ATO) and oxybutynin (OXY) has been suggested for obstructive sleep apnoea (OSA). However, the effectiveness of this treatment remains uninvestigated...
12.
Fukushi I, Yokota S, Takeda K, Terada J, Umeda A, Yoshizawa M, et al.
Brain Res
. 2022 Aug;
1795:148061.
PMID: 36037880
Suvorexant (Belsomra(R)), a dual orexin receptor antagonist widely used in the treatment of insomnia, inhibits the arousal system in the brain. However, the drug's ventilatory effects have not been fully...
13.
Takeshita Y, Terada J, Hirasawa Y, Kinoshita T, Tajima H, Koshikawa K, et al.
Front Med (Lausanne)
. 2022 Aug;
9:935255.
PMID: 36017008
Objectives: This study aims to create and validate a useful score system predicting the hyper-inflammatory conditions of COVID-19, by comparing it with the modified H-score. Methods: A total of 98...
14.
Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial
Nagata K, Horie T, Chohnabayashi N, Jinta T, Tsugitomi R, Shiraki A, et al.
Am J Respir Crit Care Med
. 2022 Jun;
206(11):1326-1335.
PMID: 35771533
The long-term effects of using a high-flow nasal cannula for chronic hypercapnic respiratory failure caused by chronic obstructive pulmonary disease remain unclear. To assess whether long-term high-flow nasal cannula use...
15.
Terada J, Fujita R, Kawahara T, Hirasawa Y, Kinoshita T, Takeshita Y, et al.
EClinicalMedicine
. 2022 Jun;
49:101484.
PMID: 35692220
Background: The effectiveness of combination therapy for COVID-19 pneumonia remains unclear. We evaluated favipiravir, camostat, and ciclesonide combination therapy in patients with moderate COVID-19 pneumonia. Methods: In this open-label phase...
16.
Ishibashi F, Wada H, Kamata T, Terada J, Tsushima K, Hayashi Y, et al.
AME Case Rep
. 2022 Apr;
6:13.
PMID: 35475011
Coronavirus disease 2019 (COVID-19) is a novel emerging disease and a major risk factor for postoperative complications, especially in thoracic surgery. However, it is unclear how previous COVID-19 infection may...
17.
Yoshioka K, Abe M, Shiko Y, Koshikawa K, Kawasaki Y, Iwasawa S, et al.
Drug Des Devel Ther
. 2022 Mar;
16:759-767.
PMID: 35345618
Background/aim: Nab-paclitaxel (Nab-PTX) has been widely used to treat several advanced cancers. Nab-PTX can cause drug-induced lung injury (DILI); however, its clinical and radiographic features have not been clarified. We...
18.
Kasai H, Terada J, Nagata J, Yamamoto K, Shiohira S, Tomikawa A, et al.
Respir Med Case Rep
. 2022 Mar;
37:101630.
PMID: 35313561
We report the case of a 29-year-old man who underwent umbilical cord blood transplantation for chronic myelogenous leukemia 14 years previously. He was diagnosed with secondary pleuroparenchymal fibroelastosis (sPPFE) following...
19.
Sugiyama A, Terada J, Shionoya Y, Hirano S, Yamamoto T, Yamanaka Y, et al.
Sleep Breath
. 2022 Jan;
26(4):1779-1789.
PMID: 35025012
Purpose: We aimed to evaluate sleep-related hypoventilation in multiple system atrophy (MSA) using polysomnography (PSG) with transcutaneous partial pressure of carbon dioxide (PtcCO) monitoring. Methods: This prospective study included 34...
20.
Takeshita Y, Terada J, Hirasawa Y, Kinoshita T, Tajima H, Koshikawa K, et al.
J Clin Med
. 2022 Jan;
11(1).
PMID: 35011875
Although previous studies have revealed that elevated D-dimer in the early stage of coronavirus 2019 (COVID-19) indicates pulmonary intravascular coagulation, the state of coagulation/fibrinolysis disorder with normal D-dimer is unknown....